Belgian multicenter in vitro study of norfloxacin.
Verbist
L
L
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D009643:Norfloxacin; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D009643:Norfloxacin